Skip to main content

REVIEW article

Front. Surg.
Sec. Otorhinolaryngology - Head and Neck Surgery
Volume 11 - 2024 | doi: 10.3389/fsurg.2024.1437468

Cisplatin Vestibulotoxicity: A Current Review

Provisionally accepted
  • 1 Baylor College of Medicine, Houston, United States
  • 2 University of Texas MD Anderson Cancer Center, Houston, Texas, United States

The final, formatted version of the article will be published soon.

    Cisplatin, a commonly used chemotherapy drug, is well-established for its ototoxic effects, primarily attributed to the damage it inflicts on cochlear hair cells. However, its impact on the vestibular system remains inadequately understood. Here, we provide a comprehensive review of existing literature concerning cisplatin-induced vestibulotoxicity.Animal studies have shown that cisplatin induces a vestibular hair cell loss that is dose-dependent, with the severity of damage also varying according to the route of administration. Notably, intratympanic and systemic injections in animal models have manifested significant damage primarily to utricular hair cells, with a lesser degree of damage observed for the other vestibular end organs. The underlying mechanisms of cisplatin induced vestibular hair cell loss include apoptosis, oxidative stress, and inflammatory cytokines.Several protective agents, such as Pifithrin-α, DAPT, Ginkgolide B, and heat shock proteins, have demonstrated efficacy in inhibiting cisplatin-induced vestibular damage in preclinical studies.Human clinical findings indicate that cisplatin treatment can cause vestibular dysfunction, characterized by symptoms ranging from transient dizziness to persistent vertigo. Challenges in diagnosis, including the limited utilization of comprehensive vestibular testing for many patients, contribute to the variability in reported outcomes.Cisplatin-induced vestibulotoxicity is a significant complication of chemotherapy, necessitating further research to understand its mechanisms and to improve diagnosis and management, ultimately aiming to enhance the quality of life for cancer patients undergoing cisplatin therapy. While extensive research has focused on the ototoxic effects of cisplatin, particularly regarding auditory dysfunction, its impact on the vestibular system remains relatively understudied, creating a notable gap in our knowledge (Prayuenyong et al., 2021). Studies in guinea pigs and rats have demonstrated vestibulotoxic effects, such as hair cell death and a decreased vestibulo-ocular reflex (VVOR) gain.

    Keywords: vestibular, oncology, Neurotology, Cisplatin, ototoxicity

    Received: 23 May 2024; Accepted: 18 Sep 2024.

    Copyright: © 2024 Fleihan, Nader and Dickman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: J. David Dickman, Baylor College of Medicine, Houston, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.